1769
Fewer subjects reported adverse events following treatment with desipramine alone than when receiving desipramine with cinacalcet (33 versus 86%), the most frequent of which (nausea and headache) have been reported for patients treated with either desipramine or cinacalcet.
 ( adverse event: reported ,  patients: Subject, nausea and headache: Effect, desipramine or cinacalcet: Treatment, desipramine: Treatment.Drug, cinacalcet: Treatment.Drug, desipramine: Treatment.Drug, desipramine: Treatment.Drug, cinacalcet: Treatment.Drug, desipramine: Combination.Drug, cinacalcet: Combination.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: reported ,  patients: Subject, nausea and headache: Effect, desipramine or cinacalcet: Treatment, desipramine: Treatment.Drug, cinacalcet: Treatment.Drug, desipramine: Treatment.Drug, desipramine: Treatment.Drug, cinacalcet: Treatment.Drug, desipramine: Combination.Drug, cinacalcet: Combination.Drug) 